Home » Topics » Regulatory » EMA

EMA
RSS

EMA updates nevirapine label for patients with HIV-1 infection

Sep. 21, 2010

Novartis Europharm withdraws Rasival MAA for essential hypertension

Sep. 21, 2010

GSK investigates reports of narcolepsy following Pandemrix vaccination

Sep. 6, 2010

MSD's Sycrest approved in Europe for biopolar disorder

Sep. 3, 2010

FDA approves Bionovo's CMC plan for Menerba

Aug. 31, 2010

EMA investigates potential relationship between Pandemrix and narcolepsy

Aug. 30, 2010

European Commission updates license for Cervarix HPV vaccine

Aug. 30, 2010

Shire's VPRIV approved in Europe for type 1 Gaucher's disease

Aug. 27, 2010

Bristol-Myers Squibb offers pipeline update for Q2 2010

Aug. 24, 2010

Amsterdam Molecular Therapeutics provides update on Glybera MAA

Aug. 23, 2010

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 10, 2026.
Hengrui discovers new Nav1.8 blockers
BioWorld Science
Researchers from Jiangsu Hengrui Pharmaceuticals Co. Ltd. and Shanghai Hengrui Pharmaceutical Co. Ltd. have patented new sodium channel protein type 10 subunit α...
Hematopoietic stem cell research points to leukemia’s early roots
BioWorld Science
Hematopoietic stem cell (HSC) research over the past century has shown that leukemia may be driven by an invisible hand of inflammation. The bone marrow and...
News in brief
BioWorld Asia
BioWorld Asia briefs for April 7, 2026
Korsana boosts Alzheimer’s work with reverse merger, $380M financing
BioWorld Science
Just over a month after emerging from stealth and disclosing a $150 million series A, Korsana Biosciences Inc. is making the leap to the public market via a...